阳普医疗科技股份有限公司
Climate Impact & Sustainability Data (2021, 2022-01 to 2022-06)
Reporting Period: 2021
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Not disclosed
Mitigation Strategies
- Not disclosed
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2022-01 to 2022-06
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced carbon emissions by implementing measures, but specific quantification is not provided.
Social Achievements
- Launched "Zhi Hu Li, Zhi Wei Lai" anti-needle stick blood collection skills competition to improve safety awareness among medical staff.
- Published "Medical Anthology" and "Atrial Fibrillation Comics" for medical knowledge dissemination.
Governance Achievements
- Implemented a stock incentive plan.
Climate Goals & Targets
Environmental Challenges
- Industry policy risks (price controls, bidding policies).
- New product and technology development risks (technical difficulties, market factors, clinical effects, cost overruns).
- Group management risks (control over subsidiaries).
- Overseas market sales risks (political and economic uncertainties, anti-dumping applications, currency fluctuations).
- Talent and technology reserve risks (competition for talent).
Mitigation Strategies
- Adjusting business strategies to adapt to national policies.
- Strengthening R&D through collaboration with research institutions and international partners.
- Strengthening control over subsidiaries.
- Monitoring political and economic situations, purchasing export credit insurance.
- Offering competitive salaries, implementing stock incentive plans, protecting intellectual property rights.